22 May 2013
Keywords: Rovi, Merck & Co, Vytorin, Absorcol, Spain, Cholesterol lowerer
Article | 19 January 2011
Spanish drugmaker Laboratorios Farmaceuticos Rovi says in a regulatory filing that it will soon be marketing the cholesterol lowerers Vytorin ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 January 2011
20 January 2011
21 May 2013
© 2013 thepharmaletter.com